Lv3
325 积分 2021-05-18 加入
uPAR: a versatile signalling orchestrator
10小时前
求助中
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models
1天前
已完结
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
20天前
已完结
Mirvetuximab Soravtansine in FRa-Positive, Platinum-Resistant Ovarian Cancer
1个月前
已完结
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
1个月前
已完结
A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial
1个月前
已完结
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors
2个月前
已关闭
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
2个月前
已完结
Small Cell Lung Cancer
2个月前
已完结
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
3个月前
已完结
皖公网安备34019202002308
